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172 The Journal of Thoracic and CardioObjective: This study was undertaken to investigate the intermediate outcomes after
the Fontan operation in the current era.
Methods: A cross-sectional analysis was performed by using data gathered between
October 13, 2003, and February 22, 2005, on all 310 survivors of the Fontan
procedure between January 1, 1992, and December 31, 1999. Medical records were
reviewed, and a customized questionnaire was administered to caregivers. Outcome
variables included failure of the Fontan operation (ie, death, takedown of Fontan, or
transplantation), number of cardiac-related rehospitalizations, parental assessment
of health, school performance, and cardiac functional status.
Results: A total of 332 patients underwent the Fontan procedure during the study
period. A lateral tunnel was constructed in 281 (85%), and an extracardiac Fontan
procedure was performed in 51 (15%). A total of 210 (63%) children had undergone
previous stage I reconstruction, and 162 (49%) had received an initial diagnosis of
hypoplastic left heart syndrome. There were 310 hospital survivors of the Fontan
procedure (93.4%), with an additional 16 deaths (5.2%) during follow-up and 1
living heart transplant patient before the cross-sectional period. For initial hospital
survivors, Kaplan-Meier estimates of freedom from death or transplantation were
98.0% (95% confidence interval, 95.6%-99.1%) at 1 year after the Fontan proce-
dure, 94.9% (91.6%-97.0%) at 5 years, and 93.9% (90.1%-96.2%) at 8 years.
Questionnaires were completed for 240 (81.9%) of the 293 available patients. By
parental recollection, a total of 130 (54.2%) children required cardiac-related
rehospitalization at some point during the follow-up period. At a median follow-up
of 8.6 years (range, 4.1-12.8 years), 94.6% of guardians described their child’s
overall health as excellent or good, and 5.4%, as fair or poor. School performance
was described as above average in 30.2%, average in 39.9%, and below average in
29.8%. With regard to cardiac functional status, 34.2% responded that their child
had no limitations to physical activity, 52.5% reported a slight limitation, 12.1%
reported a significant limitation, and 1.2% reported a severe limitation.
Conclusions: Acceptable survival outcomes have been observed at intermediate
follow-up of the Fontan operation in this cohort; a significant proportion of patients
had hypoplastic left heart syndrome. Although cardiac-related rehospitalization is
common, the parents and guardians believed that overall health, school perfor-
mance, and cardiac functional status were good to excellent for most patients.
Since the introduction of the total cavopulmonary anastomosis by Fontan andBaudet more than 30 years ago, preoperative indications, operative tech-niques, and postoperative management strategies of the Fontan patient have
all evolved significantly. Advances in echocardiography and interventional cathe-
terization techniques, along with the increased availability of prostaglandins in
recent years, have resulted in significant modifications in the treatment of patients
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Dwith a functional single ventricle. Furthermore, many of
these changes have occurred in the last 15 years, most
notably routine interim staging with an interim bidirectional
cavopulmonary anastomosis, successful completion of the
Fontan procedure for increasingly younger patients, and
routine use of baffle fenestration by many centers. However,
despite these advances and their potential effect on clinical
practice and care, few data exist on intermediate outcomes
after current Fontan modifications.
Previously, large cross-sectional studies have reported
that hypoplastic left heart syndrome (HLHS) and increasing
duration of follow-up are among the strongest predictors of
morbidity and failure of the Fontan procedure.1 If still valid
today, these are particularly troublesome findings given the
success of the Norwood procedure and the increased pro-
portion of patients with HLHS now surviving with a Fontan
circulation.
The purpose of this study was to examine the intermediate-
term survival and functional outcomes of patients with a
functional single ventricle who have undergone a Fontan
operation at a large-volume center in the current era. The
outcome variables assessed included failure of the Fontan
operation, rehospitalization, parental assessment of health,
school performance, and cardiac functional status.
Patients and Methods
Subjects
A cross-sectional follow-up study was conducted between October
13, 2003, and February 22, 2005, on all 310 survivors of 332
patients who underwent the Fontan procedure between January 6,
1992, and December 17, 1999, at the Children’s Hospital of
Philadelphia, a group for which surgical outcomes have been
previously reported.2 Patients who died or underwent cardiac
transplantation were considered to be instances of failed Fontan
circulation and were included in the survival analysis, but trans-
plantation survivors were excluded from the intermediate-term
functional analyses. Thus, for the questionnaire responders, all
patients had Fontan circulation at the time of follow-up.
Fifty patients were not able to be contacted during the cross-
sectional follow-up period but were known to be alive at some
point before the cross-sectional follow-up period. The median time
from the Fontan procedure until the last known visit in this group
was 0.7 years (range, 5.0 days to 11.0 years). Data from all 310
hospital survivors were included in the survival analysis. Survival
information was obtained on 260 patients (83.9%) within the
cross-sectional follow-up period. The median follow-up time was
8.3 years (range, 6.0 days to 12.8 years), and phone interviews
Abbreviations and Acronyms
CI  confidence interval
HLHS hypoplastic left heart syndromewith questionnaires were completed with caregivers for 240
The Journal of Thoraci(81.9%) of the 293 survivors of the Fontan procedure who had an
intact Fontan circulation at the time of the questionnaire.
Patient Contact and Perioperative Variables
Medical records including clinic notes and the cardiac surgical
database records of all patients from the Children’s Hospital of
Philadelphia were reviewed, and relevant preoperative and follow-up
data were compiled and entered into an electronic database. Pa-
tients who were not known to be deceased were contacted by
telephone, and an institutional review board–approved customized
questionnaire was administered to the caregiver of these patients
which addressed parental assessment of health status, school per-
formance, and cardiac functional status. Medical records, preop-
erative echocardiographic and cardiac catheterization data, and
operative notes were reviewed to obtain the perioperative data.
Outcome Measurements
The following outcome indices were obtained by the customized
telephone interview.
Fontan-related rehospitalizations. Parents were asked the
number and nature of all rehospitalizations after the Fontan oper-
ation. The distribution of responses was then dichotomized into 2
groups: a reference group (no rehospitalizations or 1 Fontan-related
rehospitalization) and a comparison group (2 or more Fontan-
related rehospitalizations). Reasons for rehospitalization included
surgery, day surgery, catheterizations, visits to the emergency
room, and hospital admissions. Fontan-related rehospitalization
included any cardiac admission (eg, arrhythmias, catheterizations,
or cardiac or thoracic operative procedures); any admission for
pleural effusion, protein-losing enteropathy, or surgical wound
infection; and any admission to evaluate symptoms otherwise not
specified (eg, chest pain, shortness of breath, dizziness, palpita-
tions, nausea, or dehydration) for which a clear alternative diag-
nosis was not found. Pneumonia was not considered a Fontan-
related admission.
Parental assessment of health performance. Parents were
asked to characterize their child’s current health status as excellent,
good, fair, or poor.
Parental assessment of school performance. Parents were
asked to rate their child’s school performance relative to the
child’s peers on a 3-point scale: below average, average, or above
average.
Parental assessment of cardiac functional status. Parental
assessment of cardiac functional status was accomplished by ask-
ing caregivers whether there were any limitations to the child’s
physical activity; if so, these limitations were specifically identi-
fied. Cardiac functional status was then assigned by the single
interviewer (M.E.M.).
Statistical Analysis
Data analysis occurred in 2 distinct phases: a descriptive phase and
an inferential phase. Descriptive statistics were first generated for
all relevant variables in the data set, with a particular emphasis on
patient-related, operative, postoperative, and long-term health care
factors hypothesized to have an influence on 5 specific outcomes
of interest: failure of the Fontan procedure, Fontan-related rehos-
pitalizations, parental assessment of health status, parental assess-
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Dment of school performance, and parental assessment of cardiac
functional status. Four of the 5 outcomes were dichotomous:
failure of the Fontan procedure, number of Fontan-related rehos-
pitalizations (no rehospitalizations or 1 hospitalization vs 2
hospitalizations), parental assessment of health status (excellent vs
good, fair, or poor), and parental assessment of cardiac functional
status (excellent or good vs fair or poor). The fifth outcome,
parental assessment of school performance, was polytomous (ex-
cellent, good/fair, or poor). In addition, a Kaplan-Meier curve
TABLE 1. Single-covariate risk factor model values for Fo
Risk factor  Coefficient
Patient-related factors
Age at Fontan 0.07
Anatomic diagnosis*
LV-NRGA
LV-TGA 1.02
Heterotaxy 0.74
Single RV 0.53
HLHS 1.12
AV morphology 0.82
AV valve regurgitation 0.05
Heterotaxy (Y/N) 0.22
Initial palliation†
None
BAS/shunt 0.22
Pulmonary artery band 1.03
Stage I 0.48
Stage I (Y/N) 0.20
Interim staging†
Operative factors
Type of Fontan (LT/EC) 0.70
Year of Fontan 0.01
Fenestration 0.11
Additional procedures
CPB Time 0.01
Crossclamp time 0.03
DHCA time 0.02
Total support time 0.01
Modified ultrafiltration (Y/N) 0.82
Postoperative factors
Duration of ventilation 0.01
Duration of chest tube 0.28
Duration of ICU stay 0.01
Duration of hospital stay 0.01
Long-term health care factors
Number of medications 0.18
Number of hospitalizations 0.11
Pacemaker 1.54
OR, Odds ratio; CI, confidence interval; LV-NRGA, left ventricle with normall
arteries; RV, right ventricle; HLHS, hypoplastic left heart syndrome; AV, atri
CPB, cardiopulmonary bypass; DHCA, deep hypothermia and circulatory ar
the variable name. †The interim staging variable had insufficient variability t
significant contributors to a multivariable model after adjustment for theestimating freedom from death or transplantation was constructed
174 The Journal of Thoracic and Cardiovascular Surgery ● Janufor the entire sample of hospital survivors, and freedom from death
or transplantation probabilities were computed, complete with
95% confidence intervals (CIs). This was a freedom from Fontan
failure survival curve, with time 0 defined as the date of the Fontan
procedure and with failure defined as either the date of death or the
date of heart transplantation, when known, or patients were with-
drawn alive at the time of the last known contact.
In the second phase, the inferential phase, 24 different single-
covariate logistic regression models were specified and tested for
failure
Fontan failure, OR
(95% CI) P value
1.07 (1.08-1.16) .05
.77
Reference group
2.76 (0.29-26.57) .38
2.09 (0.13-33.44) .60
1.70 (0.11-27.17) .71
3.06 (0.39-23.69) .28
2.27 (0.65-7.94) .20
1.05 (0.14-7.92) .96
0.80 (0.11-6.06) .83
.54
Reference group
0.80 (0.07-8.86) .86
2.79 (0.29-26.92) .37
1.61 (0.21-12.41) .65
1.22 (0.46-3.26) .69
Noncalculable
2.01 (0.64-6.30) .23
0.99 (0.80-1.22) .90
0.89 (0.20-3.91) .88
Noncalculable
1.01 (0.99-1.02) .22
1.03 (1.00-1.05) .02‡
1.02 (0.99-1.05) .16
1.01 (1.00-1.02) .13
0.44 (0.14-1.38) .16
1.00 (1.00-1.00) .44
1.33 (1.08-1.63) <.01
1.01 (0.99-1.03) .25
1.00 (0.99-1.01) .48
1.19 (0.41-3.46) .74
0.89 (0.23-3.42) .87
4.65 (0.29-74.83) .28
ed great arteries; LV-TGA, left ventricle with transposed or malposed great
ricular; BAS, balloon atrial septostomy; EC, extracardiac; LT, lateral tunnel;
CU, intensive care unit. *Dummy coded variable with classes listed below
d stable Cox regression model solutions. ‡Bolded terms denote statistically
f the Fontan procedure.ntan
y relat
ovent
rest; I
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Dtional hazards regression model for the survival data, simple lo-
gistic regression for the dichotomous outcomes, and multinomial
logistic regression for the categorical outcome (see Tables 1 and 2
for a listing of all covariates used). Dummy codes were initially
used for 3 categorical covariates: anatomic diagnosis, initial pal-
liation, and interim staging with cavopulmonary connection. Mul-
TABLE 2. Single-covariate risk factor model values for pa
functioning, and rehospitalization
Risk factor
Rehospitalization

Coefficient OR (95% CI)
P
value
Patient-related factors
Age at Fontan 0.05 1.05 (0.96-1.15) .25
Anatomic diagnosis* .18
LV-NRGA Reference group
LV-TGA 1.05 2.86 (0.99-8.25) .05
Heterotaxy 0.13 1.14 (0.28-4.57) .85
Single RV 0.62 1.87 (0.55-6.33) .32
HLHS 0.13 1.14 (0.45-2.91) .78
AV morphology 0.10 0.90 (0.32-2.58) .85
AV valve regurgitation 1.24 0.29 (0.04-2.31) .24
Heterotaxy (Y/N) 0.20 0.82 (0.26-2.60) .74
Initial palliation* .20
None Reference group
BAS/shunt 0.69 2.00 (0.51-7.90) .32
Pulmonary artery band 1.50 4.50 (1.01-20.11) .05
Stage I 0.68 1.98 (0.55-7.12) .30
Stage I (Y/N) 0.09 0.91 (0.50-1.65) .76
Interim staging Noncalculable
Operative factors
Type of Fontan (LT/EC) 0.86 0.42 (0.16-1.14) .09
Year of Fontan 0.11 0.89 (0.79-1.01) .08
Fenestration 0.27 0.76 (0.30-1.95) .57
Additional procedures 0.45 0.64 (0.13-3.03) .57
CPB time 0.01 1.01 (1.00-1.02) .22
Crossclamp time 0.02 1.02 (0.99-1.04) .16
DHCA time 0.03 1.03 (1.00-1.05) .02
Total support time 0.01 1.01 (1.00-1.02) .05
Modified ultrafiltration (Y/N) 0.39 0.68 (0.38-1.22) .20
Postoperative factors
Duration of ventilation 0.01 1.01 (1.00-1.02) .22
Duration of chest tube 0.27 1.31 (1.00-1.73) .05
Duration of ICU stay 0.01 1.01 (0.99-1.04) .31
Duration of hospital stay 0.01 1.00 (1.00-1.01) .32
Long-term health care factors
Number of medications 0.62 1.87 (1.40-2.49) .01
Number of hospitalizations Noncalculable
Pacemaker 2.71 15.05 (5.70-39.71) <.01
OR, Odds ratio; CI, confidence interval; LV-NRGA, left ventricle with normall
arteries; RV, right ventricle; HLHS, hypoplastic left heart syndrome; AV,
tunnel; CPB, cardiopulmonary bypass; DHCA, deep hypothermia and cir
listed below the variable name. †Bolded terms denote statistically signifi
Fontan procedure.tiple covariate models were then specified and tested by using
The Journal of Thoracisingle-covariate models with Wald statistic P values  .15 as
candidates for inclusion in the larger models. Because of recent
advances in both operative and postoperative care between 1992
and 1999, all multiple-covariate models were adjusted for the year
of the Fontan procedure. Type I error rates were held constant at
the   .05 level for all analyses. All data were analyzed with
al assessment of health, parental assessment of cardiac
arental assessment of health
Parental assessment of cardiac
functioning

ficient OR (95% CI)
P
value

Coefficient OR (95% CI)
P
value
0.22 1.24 (1.05-1.46) .01† 0.05 1.05 (0.95-1.16) .30
.74 .17
Reference group Reference group
0.16 0.85 (0.33-2.15) .73 0.55 0.58 (0.18-1.84) .35
0.06 1.06 (0.34-3.30) .92 1.02 0.36 (0.07-1.89) .23
0.12 0.88 (0.30-2.57) .82 0.44 0.64 (0.17-2.41) .51
0.43 0.65 (0.30-1.40) .27 1.21 0.30 (0.11-0.79) .02
0.21 1.23 (0.50-3.02) .65 0.41 0.66 (0.15-2.99) .59
0.09 1.10 (0.32-3.70) .88 Noncalculable
0.31 1.36 (0.52-3.56) .53 0.22 0.80 (0.18-3.66) .77
<.01 .36
Reference group Reference group
1.16 3.20 (1.02-10.02) .05 0.36 1.43 (0.35-5.81) .62
2.08 8.00 (2.01-31.80) .01 0.34 1.41 (0.27-7.26) .68
0.72 2.05 (0.71-5.90) .18 0.38 0.69 (0.18-2.61) .58
0.40 0.67 (0.40-1.13) .13 0.66 0.52 (0.24-1.10) .09
Noncalculable Noncalculable
0.12 0.89 (0.44-1.82) .75 0.64 0.53 (0.15-1.84) .32
0.03 1.03 (0.92-1.14) .63 0.06 0.94 (0.80-1.10) .45
0.22 0.80 (0.34-1.90) .62 0.03 1.03 (0.29-3.68) .97
0.88 2.42 (0.69-8.51) .17 0.45 0.64 (0.08-5.16) .67
0.01 1.00 (0.99-1.01) .76 0.01 1.00 (0.98-1.02) .79
0.01 1.00 (0.98-1.02) .69 0.01 0.99 (0.96-1.02) .50
0.01 1.00 (0.98-1.02) .90 0.01 1.01 (0.98-1.04) .58
0.01 1.00 (0.99-1.01) .85 0.01 1.00 (0.99-1.01) .98
0.36 1.43 (0.85-2.38) .17 0.07 0.93 (0.44-1.97) .86
0.01 1.01 (0.99-1.02) .36 0.01 1.00 (1.00-1.01) .28
0.05 1.05 (0.82-1.35) .70 0.16 1.18 (0.88-1.58) .27
0.02 0.98 (0.95-1.02) .32 0.01 1.00 (0.98-1.03) .69
0.01 1.00 (0.99-1.01) .78 0.01 1.00 (0.98-1.01) .83
0.31 1.37 (1.07-1.74) .01 0.19 1.21 (0.88-1.67) .25
0.33 1.39 (1.10-1.76) <.01 0.09 1.09 (0.96-1.24) .17
0.74 2.11 (0.93-4.76) .07 1.20 3.32 (1.31-8.39) .01
ed great arteries; LV-TGA, left ventricle with transposed or malposed great
entricular; BAS, balloon atrial septostomy; EC, extracardiac; LT, lateral
ry arrest; ICU, intensive care unit. *Dummy coded variable with classes
ontributors to a multivariable model after adjustment for the year of therent
P
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cant cStata 8.0 (Stata Corp, College Station, Tex).
c and Cardiovascular Surgery ● Volume 131, Number 1 175
Surgery for Congenital Heart Disease Mitchell et al
CH
DResults
Study Population
Of the 332 patients undergoing the Fontan procedure at our
institution between January 1, 1992, and December 31,
1999, 310 (93.4%) patients survived the early postoperative
period. All survivors had Fontan circulation intact at the
time of discharge. The Fontan operation involved a lateral
tunnel in 262 (84.5%) patients and an extracardiac conduit
in 48 (15.5%). At the time of the Fontan procedure, 279
(90.0%) patients underwent fenestration, and 31 (10.0%)
were nonfenestrated. There was a common atrioventricular
valve in 28 (9.0%). Data on the severity of atrioventricular
valve regurgitation at the time of the Fontan procedure were
available on 308 (99.4%) of 310 patients; regurgitation was
absent in 196 (63.6%), mild in 93 (30.2%), moderate in 17
(5.5%), and severe in 2 (0.6%). HLHS was the preoperative
diagnosis in 164 (53%) children, single right ventricle (not
HLHS) was present in 25 (8%), heterotaxy was present in
23 (7%), single left ventricle with normally related great
arteries was present in 41 (13%), single left ventricle with
transposed great arteries was present in 43 (14%), and other
diagnoses were present in 14 (5%) (Figure 1).
The overall freedom from death or transplantation rate
was 94.8%. A total of 18 late treatment failures were ob-
served; 7 of these 18 patients underwent transplantation (2
survivors), whereas 11 of the 18 died without transplanta-
Figure 1. Anatomic subtypes. LV-NRGA, Left ventricle with nor-
mally related great arteries; LV-TGA, left ventricle with trans-
posed or malposed great arteries; RV, right ventricle; HLHS,
hypoplastic left heart syndrome. Other includes indeterminate RV
or ventricle of unknown pathology.tion. All other patients surveyed continue with functioning
176 The Journal of Thoracic and Cardiovascular Surgery ● JanuFontan circulations; there were no Fontan takedowns. Pre-
operative variables of late Fontan failures included initial
diagnosis of left ventricle with normally related great arter-
ies in 1, left ventricle with transposition of the great arteries
in 3, heterotaxy syndrome in 1, single right ventricle (single
RV) in 1, HLHS in 11, and other in 1.
Of the 18 late treatment failures, 14 (78%) were lateral
tunnel Fontans, and 4 (22%) were extracardiac. Sixteen
(89%) patients underwent some form of fenestration at the
time of the Fontan procedure, whereas 2 (11%) did not. In
our analysis, there was no difference in the preoperative or
operative variables between those whose Fontan procedures
failed and those who did not experience treatment failure.
Survival models were constructed for the entire cohort;
these models treated transplantation as death at the time of
the transplantation. In both single- and multiple-covariate
models, factors related to Fontan failure were limited to an
increasing duration of crossclamp time during the Fontan
procedure (P  .04) and duration of chest tube drainage
after the Fontan operation (P  .02). Stage I reconstruction,
anatomic diagnosis, duration of deep hypothermic circula-
tory arrest at the time of the Fontan procedure, and the
presence of atrioventricular valve regurgitation at the time
of the Fontan procedure were not significant predictors of
late failure of Fontan circulation (Table 1). Kaplan-Meier
estimates of freedom from death or transplantation for the
cohort were as follows: 1 year, 98.0% (95% CI, 95.6%-
99.1%); 5 years, 94.9% (95% CI, 91.6%-97.0%); and 8
years, 93.9% (95% CI, 90.1%-96.2%) (Figure 2).
Telephone questionnaires were completed in 240 pa-
tients. Of the 240 caregivers who completed telephone
0.00
0.25
0.50
0.75
1.00
0 5 10 15
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Figure 2. Kaplan-Meier estimate of freedom from death or trans-
plantation.questionnaires, 50 (20.8%) were men, and 190 (79.2%)
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erative or perioperative variables between the group with
completed questionnaire data and those without completed
questionnaires.
Number of Rehospitalizations
By parental recollection, of the 240 patients with complete
questionnaire data, 130 (54.2%) required rehospitalization
for a cardiac-related issue during the follow-up period (Fig-
ure 3). No cardiac-related rehospitalization was required in
the follow-up period in 110 patients (45.8%). Cardiac-
related rehospitalization was required 1 or 2 times in 107
patients (44.6%) and 3 or more times in 23 patients (9.6%).
Results from the univariate models are listed in Table 2.
Significant risks for multiple cardiac-related rehospitaliza-
tions from the multivariable models include total support
time (P  .01) at the time of the Fontan procedure and the
requirement for a pacemaker after the Fontan procedure
(P  .01), with a trend toward significance for those who
underwent lateral tunnel Fontan (P  .062).
Single-covariate models were constructed to assess pre-
dictors of poor outcome at intermediate follow-up after the
Fontan procedure as assessed by parents. These models
addressed 3 broad categories: general health, school perfor-
mance, and functional status (Tables 2 and 3).
Parental Assessment of Health
Despite a large number of rehospitalizations, most caregiv-
ers—138 (57.1%)—described their child’s current health as
excellent, and 90 (37.5%) described it as good; 11 (4.6%)
rated their child’s current health as fair, and 2 (0.8%) rated
it as poor. Results from the single-covariate models are
listed in Table 2. In a multivariable covariate model of
parental assessment of health, older age at the time of the
Figure 3. Number of Fontan-related rehospitalizations per patient.Fontan procedure (P  .02), initial palliation with a pulmo-
The Journal of Thoracinary artery band (P  .01), and number of cardiac rehos-
pitalizations (P  .02) were associated with fair or poor
parental assessment of health. Before stage I reconstruction,
the presence of atrioventricular valve regurgitation at the
time of the Fontan procedure, the duration of cardiopulmo-
nary bypass, aortic crossclamp, and deep hypothermic cir-
culatory arrest during the Fontan procedure were not asso-
ciated with parental assessment of health.
Parental Assessment of Cardiac Functional Status
Using parental assessment of limitations to physical activity
by phone interview, a single examiner (M.E.M.) classified
the survivors into New York Heart Association functional
groups. New York Heart Association functional class I or II
was present in 206 (86.7%) children, and 32 (13.3%) were
in class III or IV. A single-covariate model was constructed
to assess associations with parental assessment of cardiac
functional status. These results are listed in Table 2. In a
multivariable model, only the requirement for a pacemaker
after the Fontan procedure (P  .02) was significantly
associated with lower parental assessment of cardiac func-
tional status.
Parental Assessment of School Performance
Parents were asked to rate their child’s performance in
school on a 3-point scale: below average, average, or above
average. A total of 72 (30.2%) caregivers rated their child’s
performance as below average, whereas 95 (39.9%) rated
their children’s performance as average, and 71 (29.8%)
rated it as above average. Results from the single-variable
model are shown in Table 3. In a multivariable model, there
were no significant predictors for poor school performance.
Anatomic diagnosis and operative support parameters, in-
cluding duration of deep hypothermic circulatory arrest,
were not associated with parental assessment of school
performance.
Discussion
This cross-sectional follow-up study of all 310 survivors of
the Fontan procedure between the years 1992 and 1999 at
our institution examined intermediate-term failure rates, the
frequency of rehospitalization, medication use, and parental
assessment of performance across 3 broad categories: gen-
eral health, cardiac functional status, and school perfor-
mance. Although rehospitalization was quite common (oc-
curring in more than half of the survivors, with a median
duration of follow-up of just over 8 years), freedom from
death or transplantation rates were acceptable, and parental
assessments of health, cardiac function, and school perfor-
mance were good to excellent for most patients.
Operative, perioperative, and postoperative management
of children with a functional single ventricle has evolved
considerably since the introduction of the Fontan procedure
c and Cardiovascular Surgery ● Volume 131, Number 1 177
ressio
Surgery for Congenital Heart Disease Mitchell et al
CH
Dmore than 30 years ago. Improved survival with institu-
tional experience and evolution of surgical techniques since
the introduction of the Fontan procedure has been demon-
strated by several large studies.1,3-5 Controversy remains
regarding the optimal type of Fontan reconstruction and
whether routine use of fenestration is necessary in all pa-
tients. Most reports have found little early difference in
TABLE 3. Single-covariate risk factor model values for pa
Risk factor
Parental assessment of school pe
good/fair vs poor
 Coefficient RR (95% CI)
Patient-related factors
Age at Fontan 0.03 0.97 (0.86-1.09)
Anatomic diagnosis*
LV-NRGA Reference group
LV-TGA 0.77 0.46 (0.14-1.47)
Heterotaxy 0.44 0.64 (0.17-2.41)
Single RV 0.69 2.00 (0.44-9.18)
HLHS 0.11 1.11 (0.47-2.64)
AV morphology 0.01 1.01 (0.33-3.06)
AV valve regurgitation 0.44 1.56 (0.28-8.74)
Heterotaxy (Y/N) 0.47 0.63 (0.20-1.95)
Initial palliation
None Reference group
BAS/shunt 1.35 0.26 (0.05-1.36)
Pulmonary artery band 1.79 0.17 (0.03-1.07)
Stage I 1.21 0.30 (0.06-1.45)
Stage I (Y/N) 0.04 1.04 (0.56-1.96)
Interim staging† Noncalculable
Operative factors
Type of Fontan (LT/EC) 0.63 1.88 (0.73-4.85)
Year of Fontan 0.07 1.07 (0.94-1.22)
Fenestration 0.16 1.17 (0.40-3.39)
Additional procedures 0.29 0.75 (0.18-3.09)
CPB time 0.01 1.00 (0.99-1.01)
Crossclamp time 0.01 0.99 (0.97-1.02)
DHCA time 0.01 0.99 (0.97-1.02)
Total support time 0.01 1.00 (0.99-1.01)
Modified ultrafiltration (Y/N) 0.27 1.31 (0.71-2.44)
Postoperative factors
Duration of ventilation 0.01 1.00 (0.99-1.00)
Duration of chest tube 0.14 0.87 (0.66-1.15)
Duration of ICU stay 0.02 0.98 (0.94-1.02)
Duration of hospital stay 0.01 0.99 (0.98-1.00)
Long-term health care factors
Number of medications 0.04 1.04 (0.79-1.37)
Number of hospitalizations 0.03 1.03 (0.90-1.18)
Pacemaker 0.21 0.81 (0.32-2.03)
No best-fitting multiple-covariate model could be obtained by using the v
ventricle with normally related great arteries; LV-TGA, left ventricle with tr
heart syndrome; AV, atrioventricular; BAS, balloon atrial septostomy; EC
hypothermia and circulatory arrest; ICU, intensive care unit. *Dummy cod
variable had insufficient variability to yield stable multinomial logistic regmortality when comparing lateral tunnel with extracardiac
178 The Journal of Thoracic and Cardiovascular Surgery ● Janureconstruction, although there is increasing evidence that
routine baffle fenestration decreases postoperative morbid-
ity and the length of hospital stay.6-8 With hospital mortality
and morbidity continuing to decrease, the effects of the
newer Fontan modifications will need to be judged accord-
ing to their effects on longer-term outcomes. However,
mid-term data regarding survival and the functional out-
l assessment of school performance
nce: Parental assessment of school performance:
excellent vs poor Multinomial
P valuevalue  Coefficient RR (95% CI) P value
.64 0.14 0.86 (0.72-1.04) .13 .22
Reference group .15
.19 0.61 1.85 (0.56-6.13) .32
.51 0.20 1.22 (0.28-5.37) .79
.37 1.74 5.71 (1.16-28.07) .03
.81 0.42 1.52 (0.53-4.34) .44
.98 0.18 1.20 (0.38-3.77) .75 .94
.62 0.99 2.69 (0.50-14.36) .25 .46
.42 0.35 0.70 (0.21-2.33) .56 .71
.24
Reference group
.11 1.93 0.14 (0.03-0.77) .02
.06 2.08 0.12 (0.02-0.82) .03
.13 1.63 0.20 (0.04-0.94) .04
.90 0.02 0.98 (0.50-1.91) .95 .98
Noncalculable
.19 0.82 2.28 (0.86-6.04) .10 .21
.29 0.12 1.13 (0.98-1.30) .08 .21
.77 0.16 0.85 (0.29-2.48) .76 .83
.69 0.29 0.75 (0.16-3.48) .71 .90
.87 0.01 1.00 (0.98-1.01) .74 .87
.49 0.01 0.99 (0.96-1.01) .34 .61
.50 0.02 0.98 (0.95-1.01) .17 .39
.88 0.01 0.99 (0.98-1.01) .38 .64
.39 0.53 1.71 (0.88-3.31) .11 .28
.44 0.02 0.98 (0.96-1.01) .15 .08
.32 0.66 0.52 (0.30-0.89) .02 .02
.38 0.01 1.00 (0.98-1.03) .67 .37
.36 0.01 1.00 (0.99-1.01) .82 .46
.76 0.18 0.83 (0.61-1.13) .25 .28
.64 0.22 0.80 (0.60-1.06) .12 .10
.66 0.76 0.47 (0.15-1.45) .19 .39
les presented here. RR, Risk ratio; CI, confidence interval; LV-NRGA, left
sed or malposed great arteries; RV, right ventricle; HLHS, hypoplastic left
acardiac; LT, lateral tunnel; CPB, cardiopulmonary bypass; DHCA, deep
riable with classes listed below the variable name. †The interim staging
n solutions.renta
rforma
P
ariab
anspo
, extr
ed vacomes of these most recent modifications are limited.6,8
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DOur study reports parental assessment of health perfor-
mance, cardiac functional status, and school performance of
240 survivors of the Fontan procedure between January
1992 and December 1999. In our initial article,9 we dem-
onstrated that despite a patient population composed largely
of patients with HLHS or variants thereof, mortality has
decreased dramatically in recent years, as has morbidity.
Indeed, HLHS was not a risk factor for early mortality after
the Fontan procedure.2 In this study, we similarly found that
patient-related demographic variables did not predict poor
outcomes in parental assessment of health performance,
cardiac functional status, or school performance.
Duration of chest tube drainage and crossclamp time
were found to be predictors of failure of the Fontan proce-
dure in both single-variable and multivariable models at
intermediate follow-up in this study, but they were not
found to be related to early mortality in the previous study
of this cohort.2 Although it may be the case that these are
markers for more severe cardiac pathology, this cannot be
determined in the current analysis.
Neurocognitive outcomes after the Fontan procedure
have been shown to be in the normal range for most pa-
tients, but group data are lower than expected. Most studies
have focused on cognitive testing with IQ and achievement
testing,10,11 but there is growing evidence that behavioral,
fine motor, and attention difficulties may play a larger role
in school difficulties.12 In this study, a significant proportion
of parents (30%) rated their child’s performance in school
as below average. In contrast to the report from Wernovsky
and colleagues,11 underlying anatomy and surgical support
techniques were not related to the parental assessment of
school performance. In that study, there were few patients
with HLHS, and objective testing was limited to cognitive
and achievement testing.
This study has several important limitations. Although the
study was cross-sectional, with only 82% of the surviving
cohort completing the telephone questionnaire, there was no
difference in patient- or procedure-related variables between
the groups who did and did not respond. This study is based on
qualitative parental assessment of performance. Qualitative
parental assessment data may not compare to physiological
quantitative studies, such as exercise or IQ testing. This ques-
tionnaire has not been validated as an instrument; the use of a
validated questionnaire may have resulted in different results,
and, certainly, correlation with quantitative tests such as exer-
cise or IQ testing would be informative. Although this study
represents a large cohort with a median follow-up time of 8
years, this data may not be predictive of longer-term outcome.
In this study design, we could not account for interventional or
spontaneous closure of a fenestration. Finally, the study may
have inadequate power to detect relationships of predictor
variables, for example, the duration of cardiopulmonary bypass
and functional outcome.
The Journal of ThoraciIn conclusion, at a median follow-up of 8 years, survival
with the current modifications of the Fontan operation is ac-
ceptable. Overall functional outcome was rated to be good or
excellent by caregivers in the 3 areas of general health, cardiac
functional status, and school performance. We could not de-
termine a difference in survival or functional outcomes based
on most patient- or procedure-related variables, including ven-
tricular morphology. It is important to note that postoperative
morbidities (duration of chest tube drainage and the need for
permanent pacing) are related to suboptimal findings at mid-
term follow-up, and strategies to minimize postoperative com-
plications are critical for improving longer-term health-related
quality of life. Although most parents and guardians believe
that overall functional outcomes are acceptable, objective cor-
relations are necessary. To address these considerations, ob-
jective functional, electrophysiological, and neurodevelopmen-
tal testing is currently being planned in this cohort of patients,
as is continued, comprehensive follow-up of ongoing surgical
modifications.
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DDiscussion
Dr William G. Williams (Toronto, Ontario, Canada). I appreciate
the opportunity to discuss this excellent paper and congratulate Dr
Mitchell on his presentation.
You have focused our attention on the need for changing the
end points of clinical research from mortality and morbidity to
the important area of evaluating general health, well-being, and
psychosocial assessment. It’s a compliment to our specialty that
improving survival with decreasing morbidity has reached the
point that these binary end points are now less sensitive indi-
cators of success.
The end points of mortality and morbidity are easily analyzed
because they’re irrefutable and binary. Death either does or does
not occur. Survival is portrayed in time-related graphs, as you have
illustrated.
Survival, and survival free of complications, is obviously
essential to our patients and their families. But beyond this
essential first step, parents will want some idea of the well-
being of their child and the capability to function within soci-
ety. Therefore, your attempt at parental assessment of their
child’s health, school performance, and functional status is an
important step into a new area of assessment—new, at least, for
surgeons. The clinical end points are no longer binary and
irrefutable, but qualitative.
Outcome variables such as general health perception are
sometimes referred to as “warm and fuzzy” and the research
process as “touchy-feely.” These end points are qualitative and
meaningful only when compared with a known standard, such
as a population of normal children.
By way of example, you state that parents’ perception of their
child’s health is excellent or good in 95%, yet more than half of the
children were hospitalized at some time after the Fontan. Surely
this assessment is relative to the time when their child was hospi-
talized. What is missing in your study is a reference point.
Another example is the school performance, where roughly
a third was average, a third above average, and a third below.
Surely this is the distribution of any school class. And the
important reference point of how these children compared to a
normal population would be of great interest.
180 The Journal of Thoracic and Cardiovascular Surgery ● JanuThere are tools to assist us in the qualitative assessment of
outcomes, and they are referred to as instruments. These are not
the instruments you and I are familiar with in the operating
room; they are carefully constructed questionnaires, such as the
Child Health Questionnaire or the PedsQL, that have been
tested in populations of children with and without acute or
chronic disease. These validated questionnaires provide a base-
line for comparison, and they have been translated into other
languages so that bias from different ethnicities is limited.
These reference points to control data might have allowed better
correlations with your clinical data, such as circulation arrest
times.
To be critical of your methods, your assessment is based upon
a customized questionnaire. Did you consider using any of the
established validated questionnaires? And you also imply that this
study will be continuing and with additional assessments. Will that
include a validated questionnaire by the child and by the care-
giver?
An important finding in your study is that the population of
children with hypoplastic left heart, which constituted 53% of the
total, fared as well as the rest of the single-ventricle population.
That is a tribute to the progress in treating these very sick infants
that has been led by the Philadelphia group.
Congratulations on a fine contribution and for leading the way
towards assessment of functional outcomes.
Dr Mitchell. I have to say I agree with essentially every-
thing that you present there, and you pointed out exactly the
limitations of this study. When we designed this study, we
designed it as a preliminary study, and so we decided not to use
validated questionnaires. We are proceeding with the valida-
tions in terms of gathering the physiologic data that may or may
not corroborate them, but, in the interim, we hold the view that
the parental assessment is in and of itself an important outcome
variable.
We do have data that corroborate some of these findings, but
they remain to be statistically analyzed now, and, hopefully,
that analysis, combined with the neurodevelopmental and IQ
testing and electrophysiologic data, will serve to answer these
questions.
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